Fluconazole

Phase 3Completed

0 views this week 0 watching⚡ Active

Interest: 40/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Vulvovaginal Candidiasis

Conditions

Vulvovaginal Candidiasis

Trial Timeline

Mar 5, 2013 → Nov 22, 2013

NCT ID

NCT01806623

About Fluconazole

Fluconazole is a phase 3 stage product being developed by Pfizer for Vulvovaginal Candidiasis. The current trial status is completed. This product is registered under clinical trial identifier NCT01806623. Target conditions include Vulvovaginal Candidiasis.

What happened to similar drugs?

1 of 7 similar drugs in Vulvovaginal Candidiasis were approved

Approved (1) Terminated (0) Active (6)

🔄SHR8008 + FluconazoleJiangsu Hengrui MedicinePhase 3

🔄SHR8008 capsule + Fluconazole capsuleJiangsu Hengrui MedicinePhase 3

🔄Estradiol 10 MCG Vaginal Tablet [VAGIFEM] + Promestriene VaginalNovo NordiskPhase 3

✅Clotrimazole vaginal tablet + FluconazoleBayerApproved

🔄IbrexafungerpScynexisPhase 3

🔄Fluconazole Tablet + IBREXAFUNGERP + Placebo oral tabletScynexisPhase 3

🔄Estradiol + PlaceboTherapeuticsMDPhase 3

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (14)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00002077	Pre-clinical	Completed	—	—	Meningitis, Cryptococcal
NCT00002306	Pre-clinical	Completed	—	—	Meningitis, Cryptococcal
NCT00000627	Pre-clinical	Completed	—	Nov 1, 1994	HIV Infections
NCT00002040	Pre-clinical	Completed	—	—	Meningitis, Cryptococcal
NCT00002010	Pre-clinical	Completed	—	—	Meningitis
NCT00002325	Pre-clinical	Completed	—	—	Mycoses
NCT00000744	Pre-clinical	Completed	—	Dec 1, 1995	Candidiasis
NCT00002339	Phase 3	Completed	—	—	Candidiasis, Esophageal
NCT00002038	Pre-clinical	Completed	—	—	Candidiasis
NCT00002294	Pre-clinical	Completed	—	—	Meningitis, Cryptococcal
NCT00002076	Pre-clinical	Completed	—	—	Meningitis, Cryptococcal
NCT01806623	Phase 3	Completed	Mar 5, 2013	Nov 22, 2013	Vulvovaginal Candidiasis
NCT01680458	Pre-clinical	Completed	Nov 1, 2012	Oct 1, 2014	Deep Mycosis
NCT00645242	Phase 3	Completed	Nov 1, 2002	Mar 1, 2003	Tinea Capitis

Competing Products

10 competing products in Vulvovaginal Candidiasis

See all competitors

Product	Company	Stage	Hype Score
SHR8008 + Fluconazole	Jiangsu Hengrui Medicine	Phase 3	36
SHR8008 capsule + Fluconazole capsule	Jiangsu Hengrui Medicine	Phase 3	36
Estradiol 10 MCG Vaginal Tablet [VAGIFEM] + Promestriene Vaginal	Novo Nordisk	Phase 3	40
Clotrimazole vaginal tablet + Fluconazole	Bayer	Approved	40
SCY-078 + Fluconazole	Scynexis	Phase 2	25
Ibrexafungerp	Scynexis	Phase 3	30
Fluconazole Tablet + IBREXAFUNGERP + Placebo oral tablet	Scynexis	Phase 3	30
Ibrexafungerp	Scynexis	Phase 1	19
Estradiol + Placebo	TherapeuticsMD	Phase 3	30
Oral Encochleated Amphotericin B (CAMB) + Oral Encochleated Amphotericin B (CAMB)	Matinas Biopharma	Phase 2	17